4 May 2020

• The European Commission hosts a global pledging event to support the ACT-Accelerator; it raises over € 9.8 billion. Source
• GFATM, which co-convenes the ACT-A Diagnostics pillar with the Foundation for Innovative New Diagnostics (FIND), makes an investment case for US $6 billion to expedite development of and secure global access to rapid tests, and procure tests for low-and-middle income countries (LMIC), saving the lives of 9 million people. Source

Return to the timeline